For press and partners
Media kit
The Priority Review in one page: what we cover, how we publish, who edits it, and the files to use.
What we cover
The Priority Review covers news across the life sciences industry: FDA actions, clinical trials, regulation, health policy and the business of drug and device development. Every item links to the primary source behind it, such as the FDA notice, the ClinicalTrials.gov record or the company filing.
How we publish
- The stream: short briefs every weekday, each from one primary source.
- Analysis: one bylined piece a week, read and approved by the editor.
- Data stories: the week's FDA actions, Phase 3 results and new Phase 3 trials, compiled by code from public records.
- The weekly: the week's stories and briefs in one issue on the site and by email.
Publishing since October 2026. How software is used, and how each item is labeled, is set out in our standards.
Audience
Audience figures are not published yet. We will publish reader and newsletter figures on this page once our measurement counts readers separately from automated visits.
Editor
Where to follow
- Website: thepriorityreview.com
- Newsletter: The Priority Review Weekly
- Feed: RSS
- Social: X, Bluesky, LinkedIn, Facebook, Instagram, Threads, YouTube, TikTok, Substack
Logos
Use the files; never retype the wordmark. The full set, with colors, type and usage rules, is on the brand page.
